Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Anti-prolactin Receptor Antibody LFA102

Known as: LFA102 
A neutralizing antibody against the prolactin receptor (PRLR) with potential antineoplastic activity. Upon administration, anti-prolactin receptor… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
In the era of precision medicine, the identification of new targets is a constant challenge to improve cancer therapy… Expand
Is this relevant?
2016
2016
LESSONS LEARNED Despite evidence for a role for prolactin signaling in breast and prostate tumorigenesis, a prolactin receptor… Expand
  • figure 2
  • figure 1
Is this relevant?
2016
2016
In this issue of The Oncologist, Agarwal et al. report negative results from a phase I trial of LFA102. Although “negative” in… Expand
  • table 1
Is this relevant?
2013
2013
Numerous lines of evidence suggest that the polypeptide hormone prolactin (PRL) may contribute to breast and prostate… Expand
Is this relevant?
Review
2013
Review
2013
The prolactin (PRL)-prolactin receptor (PRLR) signaling complex has been implicated in the pathology of breast and prostate… Expand
  • figure 1
  • figure 2
Is this relevant?
2013
2013
Numerous lines of evidence suggest that the polypeptide hormone prolactin (PRL)may contribute to breast and prostate… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2012
Review
2012
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Abstract Numerous lines of… Expand
  • table 1
Is this relevant?
2011
2011
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL The prolactin receptor (PRLR) is a class I cytokine… Expand
Is this relevant?